A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
Clinical trial NCT03896581 · COMPLETED
Trial details
- NCT number
- NCT03896581
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-28
- Primary completion
- 2021-12-08
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.